Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Two-Year Ban On Device Tax Clinched In Tax-Extenders Bill, Passage Expected Soon

This article was originally published in Clinica

Executive Summary

House and Senate negotiators reached a compromise agreement early Dec. 16 to place a two-year delay on the medical device tax as part of a tax-extenders bill, a move hailed by the device and medical imaging industry. However, the House and Senate still have to vote on the bill, the Protecting Americans from Tax Hikes Act of 2015, which also includes a permanent extension of the research and development tax credit.

You may also be interested in...

Sen. Klobuchar Forming Coalition To Push For Both Device, Cadillac Tax Repeal

Sen. Amy Klobuchar, D-Minn., is putting together a coalition of lawmakers who favor repeal of both the medical device excise tax and the Affordable Care Act's so-called "Cadillac tax" on high-expense health-care plans.

Atlas Biomed Unlocking Japan’s OTC Market With Direct-To-Consumer DNA And Microbiome Tests

Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus. 

Hair Supplement Linked To Cases Of Severe Hepatitis In France

France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts